SCHEMBL5732110

SCHEMBL5732110

Nc1ncnc2c1nc(O)n2Cc1ccc(F)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 10/20 0.53
ADORA1 P30542 9/20 0.53
MAPK1 P28482 2/20 0.49
FBP1 P09467 2/20 0.45
HSPA8 P11142 1/20 0.44
ADORA2B P29275 7/20 0.44
ADORA3 P0DMS8 3/20 0.43
USP2 O75604 3/20 0.43
CYP1A2 P05177 3/20 0.43
CYP3A4 P08684 3/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
HIF1A Q16665 1/20 0.42
NSD2 O96028 1/20 0.41
NSD3 Q9BZ95 1/20 0.41
PI4KA P42356 1/20 0.41
PI4K2B Q8TCG2 1/20 0.41
PI4K2A Q9BTU6 1/20 0.41
PI4KB Q9UBF8 1/20 0.41
MAP4K4 O95819 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1914306 0.86 ADORA2A (0.71) ADORA2AADORA1MAPK1FBP1ADORA2B
SCHEMBL22039147 0.84 ADORA2A (0.53) ADORA2AADORA1MAPK1ADORA2BADORA3
SCHEMBL5732559 0.84 ADORA2A (0.76) ADORA2AADORA1MAPK1ADORA2BADORA3
SCHEMBL7209444 0.81 TLR7 (0.38) HIF1AALDH1A1TSHR
SCHEMBL7209500 0.78 ALDH1A1 (0.45) FBP1ALDH1A1TSHR
SCHEMBL5730393 0.75 TLR7 (0.55) ADORA2AADORA1ADORA2BADORA3
SCHEMBL7210390 0.75 TLR7 (0.60)
SCHEMBL7210229 0.74 MPO (0.43) HIF1AALDH1A1
SCHEMBL6659204 0.73 ADORA2A (0.74) ADORA2AADORA1ADORA2BNSD2NSD3
SCHEMBL5732048 0.73 ADORA2A (0.72) ADORA2AADORA1MAPK1FBP1ADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1043021-B1 PURINE DERIVATIVES FOR THE TREATMENT OF ALLERGIC DISEASES AND SYSTEMIC LUPUS ERYTHEMATOSUS DAINIPPON SUMITOMO PHARMA CO (JP) 2006-05-03 EP disclosed
EP-0882727-B9 NOVEL PURINE DERIVATIVES SUMITOMO PHARMA (JP) 2005-06-15 EP disclosed
EP-0882727-B1 NOVEL PURINE DERIVATIVES SUMITOMO PHARMA (JP) 2004-12-01 EP disclosed
US-6376501-B1 INHIBITING OR REGULATING IMMUNE RESPONSE USING PURINE-DERIVED COMPOUND; NON-STEROIDAL COMPOUND JAPAN ENERGY CORPORATION (JP) 2002-04-23 US disclosed
EP-1043021-A1 TYPE 2 HELPER T CELL-SELECTIVE IMMUNE RESPONSE SUPPRESSORS Japan Energy Corporation (JP) 2000-10-11 EP disclosed
US-6028076-A FOR INDUCING .ALPHA.-INTERFERON IN A PATIENT HAVING HEPATITIS B OR C, BY ADMINISTERING PURINE DERIVATIVE JAPAN ENERGY CORPORATION (JP) 2000-02-22 US disclosed
EP-0882727-A1 NOVEL PURINE DERIVATIVES JAPAN ENERGY CORPORATION (JP) 1998-12-09 EP disclosed